Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Xplore and Novatek Partner to Provide Rugged Tablet Solution

Published: Tuesday, April 16, 2013
Last Updated: Tuesday, April 16, 2013
Bookmark and Share
The Novatek EM-Mobile solution creates efficiency by reducing time in the pharmaceutical environmental monitoring process.

Xplore Technologies Corp. and Novatek International announced the Novatek EM-Mobile, the latest environmental monitoring mobile application. The Novatek EM-Mobile combines a rugged tablet equipped with software designed specifically to provide real-time electronic data to increase efficiency in the environmental monitoring and manufacturing processes for the pharmaceutical and biopharmaceutical industry.

Running on an Xplore iX104C5 DMCR (Dual-Mode Clean Room) rugged tablet, the Novatek EM-Mobile solution can be utilized in the sensitive environment of clean rooms without impact, while providing the real-time information needed to manage the pharmaceutical manufacturing process. It is dustproof, waterproof, and can be sanitized using standard chemical disinfectants without damaging the product. It is impervious to harsh cleaning solvents and contaminants of all types, a major benefit needed for clean room operations.

“Our partnership with Novatek further highlights Xplore’s commitment to delivering tailored rugged tablets built to meet the sophisticated demands of the healthcare and pharmaceutical industries,” said Mark Holleran, president and chief operating officer of Xplore Technologies. “The synergy between hardware and software, between Novatek and Xplore, demonstrates how the merging of the latest technologies can be applied for the advancement and improvement in laboratory operations.”

The new Novatek EM-Mobile greatly increases operational efficiency for pharmaceutical professionals. The device streamlines the manufacturing process by facilitating real-time labeling, collection and tracking of environmental monitoring, utility monitoring and product bioburden samples. The system provides completely secure and compliant electronic data management. It also allows pharmaceutical professionals to create accurate and meaningful analysis through the software’s robust reporting, trending and facility/clean room mapping capabilities.

“Through the partnership with Xplore Technologies, we are able to further cater to the pharmaceutical industry by creating a completely mobile product that improves operational efficiency, reduces risk and improves quality in the environmental monitoring and manufacturing process,” said Mike O’Grady, director of sales and marketing for Novatek International. “Xplore not only makes the most rugged tablet on the market but also meets stringent clean room standards—a major factor in our decision for partnering with the company.”

Integrating with Novatek International’s environmental monitoring management software, the Nova-EM, the Novatek EM-Mobile solution module is compliant with 21 CFR Part 11 regulations, which enables it to serve as the system of record for all environmental monitoring and utility monitoring information. The complete package consists of a wireless barcode scanner, wireless barcode printer, a stainless steel cart and mount that can be used to store and transport sampling media, and various air sampling and particle counter equipment.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!